S. 293 (105th): A bill to amend the Internal Revenue Code of 1986 to make permanent the credit for clinical testing expenses for certain drugs for rare diseases or conditions.

Introduced:

Feb 10, 1997
105th Congress, 1997–1998

Status:
Died in a previous Congress

This bill was introduced on February 10, 1997, in a previous session of Congress, but was not enacted.

Sponsor:

Orrin Hatch
Senator from Utah
Republican

Text:

Read Text »
Last Updated: Feb 10, 1997
Length: 2 pages

About the bill

Summary (CRS)
2/10/1997--Introduced.Amends the Internal Revenue Code to extend permanently the tax credit for expenses of clinical testing of certain drugs for rare diseases or conditions.

Read more >

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

H.R. 1169 (identical)

Referred to Committee
Last Action: Mar 20, 1997

What is a bill?

The “S.” in “S. 293” means this is a Senate bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

The bill’s title was written by its sponsor.

History

Introduced
Feb 10, 1997

Details

Cosponsors
23 cosponsors (14D, 9R) (show)
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.

Votes

There have been no votes related to this bill.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Citation

Click a format for a citation suggestion: